Endpoints News ١ يونيو ٢٠٢٦ Servier signs $1.55B upfront deal for Edgewise's muscular dystrophy assets
Thermo Fisher ١ يونيو ٢٠٢٦ Thermo Fisher Scientific Expands Orbitrap Innovation Across Research, Biopharma and Applied Testing at ASMS 2026 - The Joplin Globe
Thermo Fisher ١ يونيو ٢٠٢٦ Thermo Fisher Scientific Expands Orbitrap Innovation Across Research, Biopharma and Applied Testing at ASMS 2026 - Business Wire
GE HealthCare ١ يونيو ٢٠٢٦ GE HealthCare Focuses on Expanding Access to Nuclear Medicine Through AI, Radiopharmaceutical and Imaging Innovations - Business Wire
kamoer Fluid Tech (Shanghai) Co.,Ltd. ١ يونيو ٢٠٢٦ Customized (OEM) Peristaltic Pump Market Share Driven - openPR.com
LabCorp ١ يونيو ٢٠٢٦ Labcorp announces partnership for colorectal cancer trials - Clinical Trials Arena
FierceBiotech ١ يونيو ٢٠٢٦ Lilly locks in 5-program R&D pact with China’s Haisco worth up to $3B, but targets unclear
Eli Lilly ١ يونيو ٢٠٢٦ Lilly locks in 5-program R&D pact with China’s Haisco worth up to $3B, but targets unclear - Fierce Biotech
Endpoints News ١ يونيو ٢٠٢٦ #ASCO26: Erleada succeeds in early-stage prostate cancer study, but questions remain
Edwards Lifesciences ١ يونيو ٢٠٢٦ Edwards Lifesciences (EW) Investor Outlook: A 11.78% Potential Upside in the Medical Device Sector - DirectorsTalk Interviews
Samsung Biologics ١ يونيو ٢٠٢٦ Samsung creates ₩200 bil. fund to invest in global biotech ventures - koreabiomed.com
FierceBiotech ١ يونيو ٢٠٢٦ Lilly pens $1.2B deal for Hanmi’s GLP-2 drug being aimed at short bowel syndrome